Estados financieros detallados de MaxCyte, Inc. (MXCT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
MaxCyte, Inc. registró ingresos de $33.0M en el último ejercicio fiscal, con un CAGR de 5 años del 4.8%.
Márgenes de los últimos 12 meses: margen bruto 79.4%, margen operativo -111.6%, margen neto -114.8%.
Al precio actual de $1.18, MXCT presenta beneficios negativos (P/E no significativo) y un ROE del -21.01%. La capitalización bursátil es de $126M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $12.3M | $14.0M | $16.7M | $21.6M | $26.2M | $33.9M | $44.3M | $41.3M | $38.6M | $33.0M |
| Coste de Ventas | $1.3M | $1.5M | $1.8M | $2.5M | $2.8M | $3.6M | $5.1M | $4.7M | $7.1M | $6.2M |
| Beneficio Bruto | $11.0M | $12.5M | $14.8M | $19.1M | $23.4M | $30.2M | $39.2M | $36.5M | $31.5M | $26.8M |
| I+D | $4.7M | $11.3M | $11.2M | $17.6M | $17.7M | $15.4M | $19.5M | $23.8M | $22.2M | $20.8M |
| Generales y Administrativos | $9.0M | $10.5M | $12.0M | $13.4M | $15.7M | $31.7M | $44.5M | $57.0M | $56.4M | $47.0M |
| Gastos Operativos | $13.7M | $21.8M | $23.3M | $31.5M | $34.5M | $48.4M | $66.5M | $84.8M | $82.7M | $72.1M |
| Beneficio Operativo | -$2.7M | -$9.3M | -$8.4M | -$12.4M | -$11.1M | -$18.2M | -$27.4M | -$48.3M | -$51.2M | -$45.3M |
| EBITDA | -$2.6M | -$9.1M | -$7.9M | -$11.6M | -$9.9M | -$16.6M | -$20.7M | -$33.8M | -$36.3M | -$39.5M |
| Gastos por Intereses | $637800 | $625300 | $614600 | $681100 | $825600 | $1.0M | $126900 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.3M | -$9.9M | -$8.9M | -$12.9M | -$11.8M | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$3.3M | -$9.9M | -$8.9M | -$12.9M | -$11.8M | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| BPA | $-0.10 | $-0.20 | $-0.17 | $-0.24 | $-0.18 | $-0.22 | $-0.19 | $-0.37 | $-0.39 | $-0.42 |
| BPA Diluido | $-0.10 | $-0.20 | $-0.17 | $-0.24 | $-0.18 | $-0.22 | $-0.19 | $-0.37 | $-0.39 | $-0.42 |
| Acciones en Circulación (Diluidas) | $33.5M | $48.6M | $51.2M | $56.4M | $69.5M | $90.6M | $101.7M | $103.3M | $104.8M | $106.4M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $11.7M | $25.3M | $11.2M | $15.2M | $18.8M | $47.8M | $11.1M | $46.5M | $27.9M | $20.1M |
| Inversiones a Corto | 0 | 0 | $3.2M | $1.5M | $16.0M | $207.3M | $216.3M | $121.8M | $126.6M | $83.0M |
| Cuentas por Cobrar | $2.4M | $3.2M | $4.9M | $3.2M | $5.2M | $6.9M | $11.2M | $5.8M | $4.7M | $3.5M |
| Inventario | $1.3M | $1.3M | $2.2M | $3.7M | $4.3M | $5.2M | $8.6M | $12.2M | $8.9M | $7.5M |
| Activos Corrientes | $15.8M | $30.6M | $22.4M | $24.5M | $45.3M | $270.4M | $252.3M | $190.2M | $171.7M | $118.4M |
| Inmovilizado Material | $281500 | $847600 | $1.8M | $5.5M | $6.5M | $13.4M | $33.6M | $34.8M | $30.5M | $28.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $650000 |
| Activos Totales | $16.1M | $31.4M | $24.3M | $30.0M | $51.8M | $284.1M | $286.7M | $268.3M | $239.5M | $202.5M |
| Cuentas por Pagar | $3.2M | $4.3M | $1.0M | $2.1M | $890200 | $1.8M | $292000 | $743000 | $1.4M | $1.4M |
| Deuda a Corto | 0 | $850900 | 0 | 0 | 0 | 0 | 0 | 0 | $864000 | $1.5M |
| Pasivos Corrientes | $5.7M | $7.2M | $6.6M | $9.3M | $11.6M | $15.6M | $15.4M | $17.9M | $15.8M | $14.3M |
| Deuda a Largo | $5.0M | $4.2M | $5.1M | $4.9M | $4.9M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $11.0M | $11.8M | $12.0M | $16.4M | $18.6M | $21.2M | $32.7M | $36.1M | $33.2M | $31.0M |
| Reservas | -$51.7M | -$61.6M | -$70.5M | -$83.4M | -$95.2M | -$114.3M | -$137.9M | -$175.8M | -$216.9M | -$261.5M |
| Patrimonio Neto | $5.1M | $19.6M | $12.3M | $13.6M | $33.2M | $262.9M | $254.0M | $232.2M | $206.3M | $171.5M |
| Deuda Total | $5.0M | $5.0M | $5.1M | $7.2M | $7.0M | $5.7M | $16.1M | $18.7M | $18.0M | $17.9M |
| Deuda Neta | -$6.7M | -$20.3M | -$9.4M | -$9.5M | -$27.8M | -$249.4M | -$211.2M | -$149.5M | -$136.4M | -$85.1M |
| Capital Circulante | $10.1M | $23.3M | $15.9M | $15.1M | $33.6M | $254.8M | $236.8M | $172.3M | $155.9M | $104.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$3.3M | -$9.9M | -$8.9M | -$12.9M | -$11.8M | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| Amortizaciones | $105700 | $142900 | $344000 | $613500 | $1.0M | $1.4M | $2.7M | $4.6M | $4.3M | $5.1M |
| Compensación en Acciones | $154100 | $514500 | $1.3M | $1.8M | $2.5M | $8.0M | 0 | $14.0M | 0 | $9.2M |
| Cambio en Capital Circulante | $669200 | -$518800 | -$3.5M | $1.6M | -$858200 | -$1.6M | -$3.2M | $3.8M | -$751000 | -$6.1M |
| Flujo de Caja Operativo | -$2.3M | -$9.7M | -$10.5M | -$8.8M | -$8.8M | -$10.7M | -$14.8M | -$21.7M | -$27.6M | -$34.4M |
| Inversiones (CapEx) | -$218800 | -$609700 | -$709700 | -$1.3M | -$2.1M | -$3.8M | -$18.5M | -$3.7M | -$1.7M | -$1.8M |
| Adquisiciones | 0 | 0 | 0 | -$1.7M | 0 | 0 | 0 | 0 | 0 | -$1.8M |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.6M | -$10.3M | -$11.2M | -$10.1M | -$10.9M | -$14.5M | -$33.3M | -$25.4M | -$29.3M | -$36.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +14.0% | +19.2% | +29.7% | +21.0% | +29.5% | +30.6% | -6.7% | -6.4% | -14.5% | |
| Crecimiento Beneficio Neto (anual) | -196.4% | +10.6% | -45.4% | +8.4% | -61.5% | -23.5% | -60.9% | -8.3% | -8.7% | |
| Crecimiento BPA (anual) | -100.4% | +15.0% | -41.2% | +25.0% | -22.2% | +13.6% | -94.7% | -5.4% | -7.7% | |
| Cambio en Acciones (anual) | +45.1% | +5.2% | +10.2% | +23.2% | +30.5% | +12.2% | +1.5% | +1.5% | +1.5% | |
| Crecimiento FCF (anual) | -302.8% | -8.8% | +10.0% | -7.7% | -33.7% | -129.2% | +23.7% | -15.3% | -23.6% | |
| Margen Bruto | 89.3% | 89.6% | 89.0% | 88.4% | 89.4% | 89.2% | 88.5% | 88.5% | 81.6% | 81.2% |
| Margen Operativo | -22.2% | -66.4% | -50.5% | -57.4% | -42.3% | -53.7% | -61.8% | -117.0% | -132.5% | -137.1% |
| Margen EBITDA | -21.2% | -65.4% | -47.5% | -53.7% | -38.0% | -49.0% | -46.9% | -81.7% | -93.9% | -119.6% |
| Margen Neto | -27.3% | -70.9% | -53.2% | -59.6% | -45.2% | -56.3% | -53.3% | -91.8% | -106.3% | -135.1% |
| Margen FCF | -20.8% | -73.6% | -67.2% | -46.6% | -41.5% | -42.8% | -75.1% | -61.5% | -75.8% | -109.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.08 | $-0.21 | $-0.22 | $-0.18 | $-0.16 | $-0.16 | $-0.33 | $-0.25 | $-0.28 | $-0.34 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $33.5M | $48.6M | $51.2M | $56.4M | $69.5M | $90.6M | $101.7M | $103.3M | $104.8M | $106.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -21.01% |
| Rentabilidad sobre capital invertido | -19.66% |
| Rentabilidad sobre activos | -19.30% |
| Margen bruto | 79.43% |
| Margen operativo | -111.63% |
| Margen neto | -114.77% |
Salud financiera
| Deuda / Patrimonio | 0.11 |
| Ratio corriente | 12.26 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 1.43 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -170.34 | -85.00 | -100.00 | -70.83 | -94.44 | -46.32 | -28.74 | -12.70 | -10.67 | -3.69 |
| P/VC | 112.08 | 42.20 | 70.85 | 70.49 | 35.54 | 3.51 | 2.19 | 2.09 | 2.11 | 0.96 |
| P/V | 46.44 | 59.13 | 52.21 | 44.34 | 45.13 | 27.24 | 12.55 | 11.76 | 11.29 | 4.99 |
| Margen Bruto | 89.3% | 89.6% | 89.0% | 88.4% | 89.4% | 89.2% | 88.5% | 88.5% | 81.6% | 81.2% |
| Margen Operativo | -22.2% | -66.4% | -50.5% | -57.4% | -42.3% | -53.7% | -61.8% | -117.0% | -132.5% | -137.1% |
| Margen Neto | -27.3% | -70.9% | -53.2% | -59.6% | -45.2% | -56.3% | -53.3% | -91.8% | -106.3% | -135.1% |
Empresas relacionadas: ARMP · AVR · CATX · LNSR · NNOX · OWLT · PRE
Explorar sector: Healthcare · Biotechnology
Más secciones de MXCT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones